MSI2 and hepatocellular carcinoma: reported that Musashi-2 (MSI2), a member of the Musashi family, upregulated β-catenin and TCF-4/LEF-1 expression, promoting hepatitis B virus-related HCC progression via the Wnt/β-catenin pathway (74).